Adena Healthcare Collaborative LLC

Transparency is one important aspect of patient centeredness and patient engagement in the Medicare Shared Savings Program (MSSP). We believe public reporting aids transparency and can promote more informed patient choice, provide feedback to stakeholders and providers, help improve quality and lower the cost of care, and improve oversight with respect to Adena Healthcare Collaborative, LLC's compliance with program requirements. This page provides important information for the public about Adena Healthcare Collaborative, LLC.

Providing the full spectrum of health care services within the Adena Health System is consistent with the stated purposes of the Medicare Shared Savings Program and the mission of Adena.  In-network care coordination provides more efficient and effective care for our patients.  As such, the governing body of Adena Healthcare Collaborative, LLC has determined that, in order to further the interests of the Accountable Care Organization (ACO) as a whole in meeting the objectives of the Medicare Shared Savings Program, it is reasonably necessary for Adena Healthcare Collaborative, LLC to include an in-network care coordination component and care coordination engagement factor in the Adena Medical Group.  The in-network care coordination component and care coordination factor will be made available to all eligible Adena Healthcare Collaborative, LLC ACO participants and ACO providers and suppliers. 

ACO Name and Location

Adena Healthcare Collaborative, LLC
272 Hospital Road
Chillicothe, Ohio 45601

ACO Primary Contact

Primary Contact Name

Bambi Huffman

Primary Contact Phone Number

740-542-4ACO (4226)

Primary Contact Email Address

bhuffman@adena.org

Organizational Information

ACO participants:

ACO Participants

ACO Participant in Joint Venture (Enter Y or N)

Adena Medical Group, LLC

N

Greenfield Area Medical Center

N

Pike Health Services Inc

N

Adena Health System

N

 

ACO governing body:

Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Carlson

Lisa 

 Chairperson

 

ACO Particpant Representative 

Adena Health System

Justice

Jay 

 

 

ACO Particpant Representative 

Adena Health System

Jetty, MD

Satish 

 

 

ACO Particpant Representative  

Adena Medical Group, LLC

Freeman, MD

Anthony 

 

 

ACO Particpant Representative  

Adena Medical Group, LLC 

Kittaka, MD

Harry Takaji 

 

 

ACO Particpant Representative 

Adena Medical Group, LLC 

Violette, MD

Robert 

 

 

ACO Particpant Representative  

Adena Medical Group, LLC 

Livingston

Martha 

 

 

ACO Particpant Representative  

Adena Health System 

Beatty

William 

 

 

Medicare Beneficiary 

 

 

Key ACO clinical and administrative leadership:

Bambi Huffman

ACO Executive

Harry Kittaka

Medical Director

Tim Cahill

Compliance Officer

Rhett Holland

Quality Assurance/Improvement Officer

 

Associated committees and committee leadership:

Committee Name

Committee Leader Name and Position

 Finance & Clincal Quality Committee

 Dr. Robert Violette, Chair

 Data & Analytics Committee

Jason Monroe & Rachel Collier, Co-Chairs 

 

 

 

 

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals
  •  Hospital employing ACO professionals
  •  Critical Access Hospital (CAH) billing under Method II

 

Shared Savings and Losses

Amount of Shared Savings/Losses

  • First Agreement Period
  • Performance Year 2016, $4,453,320
  • Performance Year 2015, $2,551,721

Shared Savings Distribution

  • First Agreement Period
  • Performance Year 2016
      • Proportion invested in infrastructure: 28%
      • Proportion invested in redesigned care processes/resources: 8%
      • Proportion of distribution to ACO participants: 64%
  • Performance Year 2015
      • Proportion invested in infrastructure: 25% to cover start-up
      • Proportion invested in redesigned care processes/resources: n/a
      • Proportion of distribution to ACO participants: 75% (60% to PCPs & Specialists and 40% to Hospitals) 

Quality Performance Results

2016 Quality Performance Results:

ACO# 

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information

81.82

79.9

ACO-2

CAHPS: How Well Your Providers Communicate

94.62

92.63

ACO-3

CAHPS: Patients' Rating of Provider

94.13

91.93

ACO-4

CAHPS: Access to Specialists

82.59

83.52

ACO-5

CAHPS: Health Promotion and Education

57.35

60

ACO-6

CAHPS: Shared Decision Making

74.62

75.28

ACO-7

CAHPS: Health Status/Functional Status

69.97

71.82

ACO-34

CAHPS: Stewardship of Patient Resources

27.43

27.52

ACO-8

Risk-Standardized, All Condition Readmission

14.35

14.7

ACO-35

Skilled Nursing Facility 30-Day All-Cause Readmission Measure (SNFRM)

17.76

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

39.42

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

62.18

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

48.2

59.81

ACO-9

Ambulatory Sensitive Conditions Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

9.21

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8 )

9.38

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

100

82.72

ACO-39

Documentation of Current Medications in the Medical Record

99.83

87.54

ACO-13

Falls: Screening for Future Fall Risk

79.15

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

53.42

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

73.29

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow Up

47.94

74.45

ACO-17

Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention

97.72

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

47.25

53.63

ACO-19

Colorectal Cancer Screening

74.51

61.52

ACO-20

Breast Cancer Screening

85.9

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-up Documented

54.67

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

73.26

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control

15.61

18.24

ACO-41

Diabetes: Eye Exam  

43.19

44.94

ACO-28

Hypertension (HTN): Controlling High Blood Pressure

72.11

70.52

ACO-30

Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic

91.82

85.05

ACO-31

Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

94.12

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

94.92

79.67

 

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.   

Note: In the Quality Performance Results file(s) above, search for “Adena Healthcare Collaborative, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A60506 in the public use files on data.cms.gov.

Payment Rule Waivers

  • No, our ACO does not use the SNF 3-Day Rule Waiver.